Dynamic Epitope Expression from Static Cytometry Data: Principles and Reproducibility by Jacobberger, James W. et al.




2, Sree N. Sreenath
2, Michael C. Weis
2, Tammy Stefan
1
1Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, United States of America, 2Department of Electrical Engineering and Computer
Sciences, Case Western Reserve University, Cleveland, Ohio, United States of America
Abstract
Background: An imprecise quantitative sense for the oscillating levels of proteins and their modifications, interactions, and
translocations as a function of the cell cycle is fundamentally important for a cartoon/narrative understanding for how the
cell cycle works. Mathematical modeling of the same cartoon/narrative models would be greatly enhanced by an open-
ended methodology providing precise quantification of many proteins and their modifications, etc. Here we present
methodology that fulfills these features.
Methodology: Multiparametric flow cytometry was performed on Molt4 cells to measure cyclins A2 and B1, phospho-S10-
histone H3, DNA content, and light scatter (cell size). The resulting 5 dimensional data were analyzed as a series of bivariate
plots to isolate the data as segments of an N-dimensional ‘‘worm’’ through the data space. Sequential, unidirectional
regions of the data were used to assemble expression profiles for each parameter as a function of cell frequency.
Results: Analysis of synthesized data in which the true values where known validated the approach. Triplicate experiments
demonstrated exceptional reproducibility. Comparison of three triplicate experiments stained by two methods (single cyclin
or dual cyclin measurements with common DNA and phospho-histone H3 measurements) supported the feasibility of
combining an unlimited number of epitopes through this methodology. The sequential degradations of cyclin A2 followed
by cyclin B1 followed by de-phosphorylation of histone H3 were precisely mapped. Finally, a two phase expression rate
during interphase for each cyclin was robustly identified.
Conclusions: Very precise, correlated expression profiles for important cell cycle regulating and regulated proteins and their
modifications can be produced, limited only by the number of available high-quality antibodies. These profiles can be
assembled into large information libraries for calibration and validation of mathematical models.
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Introduction
Investigators often determine expression of various biochemical
activities (e.g., protein synthesis; specific phosphorylations) as a
function of the cell cycle to obtain an initial indication that the
activity has a cell cycle function. For measurement of specific
proteins and specific modified protein residues, this is usually
accomplished by synchronization, timed sampling, and immuno-
blotting or immunofluorescence/immunohistochemistry and mi-
croscopy. Often, the degree of synchrony and the cell cycle phase
distributions within each sample are monitored by DNA content
flow cytometry. The same information is available on asynchro-
nous samples using multi-variate cytometry for DNA content
coupled with immunofluorescence. Expression of the cyclin
proteins as a function of DNA content illustrates the general types
of bivariate patterns that result from ,phase specific oscillating
expression [1,2]. At a glance, the experienced investigator can
determine whether expression peaks in G1, S, 4C cells, or at phase
interfaces.
Specific mitotic markers are expressed rapidly at the onset of M,
and DNA content plus a mitotic marker expands phase resolution
by cytometry to G1, S, 4C, and M cells. For somatic cells, adding
either cyclin A2 or cyclin B1 to DNA and a mitotic marker
expands the phase list to a complete cell cycle: G1, S, G2, and M
for the 2C R 4C stemline and the same phases for endo-
reduplicated or multi-nucleate sub-cycles [3-5].
Generally, the expression of additional markers might be
expressed as the average immunofluorescence per each of these
phases [6]. However, this view is limited, and we have previously
explored the ability to extract expression at high resolution from
cytometry data on a relative time basis. In Jacobberger et al. [7],
we showed aspects of the basic process, which is to use the
correlated expression of DNA and another biomarker to obtain
the median sub-population levels of the biomarker as a function of
DNA content when DNA is ‘‘synthesized’’ in S phase. This is
possible because cytometry of an asynchronous population
captures some cells at each point in a programmed process –
i.e., incremental levels of the marker map the process. This works
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e30870for DNA and S phase because DNA synthesis is programmed. A
key element demonstrated by Jacobberger et al. is that expression
can be mapped in cell cycle phases in which rising or falling
markers were not co-expressed, if (1) we have evidence that
synthesis or degradation is uni-directional and (2) we have a means
to measure the distribution of the marker in a state where
expression is essentially not changing and thus, is more narrowly
distributed relative to the phases in which levels are changing. In
that work, we measured the rising expression of cyclin B1 in G1
and G2 cells by multi-Gaussian modeling, using the distribution in
mitotic cells to determine the initial means and standard deviations
for the model components. To put the center values determined by
each Gaussian component onto an expression versus time profile,
the values were plotted in a uniform, incremental manner over
hypothetical periods that are typical for the length of G1, S, and
G2+M (excluding the degradation of cyclin B1 in late mitosis).
While this was an effective means to display the expression features
underlying the cytometry data, and provided a method to read
fold-expression levels as function of the cell cycle, it was not
quantitative with respect to time. Recently, in an effort directed at
converting the relative fluorescence data to molecules, we used the
frequency information from cytometry data as a surrogate for time
[8]. In that study, we converted the median fluorescence within
contiguous regions that traced the cell cycle expression ‘‘back-
bone’’ in bivariate plots of cyclin B1 versus DNA content to
numbers of molecules and plotted those values versus the
cumulative frequency for all regions encompassing G1, S, G2,
and M through metaphase. Since the cell frequency is related to
the residence time within any defined region on the bivariate plots
for the population at the time of fixation, these plots reflect
expression versus cell cycle time. In that work, the focus was on
converting fluorescence to molecules and the process of deriving
expression versus time was used in its simplest and a statistically
loose form. Here, we present a multi-variate analysis that supports
complete extraction of expression profiles from the beginning to
the end of the cell cycle, improve accuracy, and explore precision
of this process. Additionally, we validate multiple sampling,
independent analysis, and synthesis of integrated expression
profiles for multiple markers as opposed to multi-parametric
analysis in which all markers under study are measured
simultaneously. This has the distinct value of opening this
quantitative approach to an unlimited, N-dimensional biomarker
analysis. Throughout the integrated results and discussion, we are
oriented to use of this measurement and analysis system to support
mathematical cell cycle modeling by systems of ordinary
differential equations [9].
Note: in this paper, we refer to 4C cells. These are cells with 4
genome complements. They can be stemline G2 + stemline M +
4C G1 cells of endoreduplicated or bi-nucleate progeny or they
can be stemline G2 + 4C G1 cells depending on the bivariate view
and/or how the data are gated.
Results and Discussion
The type of data that encodes complete cell cycle expression
information is typified by single cell DNA content measurements
from exponentially expanding cell populations. The frequency
distribution for DNA content of many individual, asynchronous
G1, S, and G2+M cells (perfectly measured) describes the
programmed expression for DNA over one expression period,
which is the cell cycle time (Tc). Within this program, there are
three states, two defined by constant DNA levels that differ by a
factor of 2, and one defined by net DNA synthesis. These states are
equivalent to kinetically defined G1, S, and G2+M phases. The
frequencies of measured G1, S, and G2+M cells are directly
proportional to the residence time in each phase or state after
adjustment for the age distribution resulting from binary division
[10,11]. Figure 1 shows a hypothetical expression profile for
DNA, typical for cultured mammalian somatic cells, with each
simulated cell measurement occupying a discrete position along
the program continuum. The length of each of the three segments
relative to the abscissa in Figure 1 is proportional, after
adjustment for age distribution, to the size (area) of components
in a typical DNA content analysis of an asynchronous cell
population measured by cytometry [12]. Histograms of these data
are often modeled with three major components: two bounding
Gaussian functions and a compound center function that can take
several forms with a multi-Gaussian summation being the most
versatile [13]. The shape, defined by immediate amplitudes of the
sub-component representing the middle segment (S phase) is a
function of the rate(s) of DNA synthesis during S phase [12]. The
general purpose of modeling histograms is to estimate the number
of cells in G1, S, and G2+M in an accurate manner. In a multi-
Gaussian model, G1 and G2+M phases are single model
components, but S phase is sub-divided into a variable number
of sub-components, each defined by a Gaussian function. To
extract the expression information from a DNA content
histogram, the center values of each component or sub-component
are plotted at the center of an interval equal to the fraction of cells
in the component/sub-component on a scale of 0–1, with 1=Tc.
Figure 2A shows a theoretical distribution built from multiple
Gaussian functions that closely matches typical cytometry data.
Proof-of-principle
To extract expression information from cytometry data, there
are two facets to the problem. The first is to define expression over
‘‘stretches’’ of ‘‘time’’ where programmed expression increases or
decreases for a single cell as a function of time, and for cytometry
data, cells representing each point along that expression curve (see
Figure 1) have been measured. Within these ‘‘stretches’’ multi-
Gaussian fitting (to account for measurement error) or contiguous
arbitrary division of the data into bins (regions) should not be
statistically different (since both provide center values for
expression and an arbitrary length of Tc fraction based on
Figure 1. Fundamental Principle of Cytometry. Random sampling
from an asynchronous population and measurement (on a cell-by-cell
basis) of a parameter that reads out a programmed process populate
the programmed expression profile at every point from the beginning
of the cell cycle to the end. The example shows a ‘‘cell’’ at each point in
time through the programmed expression of DNA content.
doi:10.1371/journal.pone.0030870.g001
Cell Cycle Expression
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e30870frequency of measurements associated with that center value. The
second facet is that for data regions where the underlying state is
constant expression values, the error does have to be estimated
and either a Gaussian component fitting or region set to enclose
data that vary due to measurement error. Sub-dividing these
clusters would lead to erroneous expression curves, since the
statistical variation would be measured as either decreases or
increases of expression. Both of these facets are illustrated in
Figure 1A by the vertical lines that define regions or the Gaussian
traces (blue) that define both a model fit and the entire distribution
(sum of the Gaussians). The only significant difference between an
apparent ‘‘ideal’’ approach of multi-Gaussian fitting and the
practical, empirical approach of using cursor-delimited regions
should be at the major transition boundaries - when the expression
slope changes. To test this assertion, we synthesized data similar to
that of a typical DNA content histogram and compared the known
expression information from the synthetic data to expression
extracted from the same data by contiguous regions (Figure 2A).
This exercise also illustrates the fundamental process of expression
extraction. The histogram in Figure 2A illustrates a one
parameter distribution, simulating a DNA histogram with 60%
G1, 30% S, and 10% G2+M. These data were synthesized using 8
normal Gaussian distributions and therefore, the perfect solution
for extraction from the composite histogram is a multi-Gaussian fit
with single Gaussian components for G1 and G2+M and 6 S
phase components (using the same means, standard deviations,
and areas that were used to generate the composite). The mean
values for each Gaussian component (Y axis) were plotted as
described above (Figure 2B, blue symbols). For the expression
profile to be complete, additional data points were created to
occupy the ends (Y intercepts at X=0 and 1) and to place at the
boundaries where expression changed (arrows). The Gaussian
components (Figure 2A) and data (Figure 2B) are numbered. The
generated points (arrows) were generated by extrapolation. We
then analyzed the same histogram using contiguous regions
(dashed divisions, Figure 2A) and plotted the center values using
the same logic in Figure 2B (brown/orange symbols). Potentially,
the part of this manual procedure where most error could occur is
choosing the region boundaries between components (regions 1
and 8). However, the agreement between the manual procedure
and the perfect solution is quite good. Therefore, we conclude that
we are correct, the error in using the less accurate, more empirical
approach is sufficient to obtain the cell cycle related programmed
expression of biochemical activities.
The idea of translating cell-based DNA content measurements
to an expression trace is obvious from theory [10,11], but seldom if
ever done, likely because the expression program can be imagined
accurately and therefore, the need to plot DNA expression doesn’t
exist. The idea is valid for any other parameter, and for other
parameters with more complex expression programs, the need
does exist, but the exercise has not been done except for isolated
partial attempts [7,8,14]. Therefore, we set out to derive the
expression of DNA content, cyclin A2, cyclin B1, and phosphor-
ylation of histone H3 (PHH3) from multiparametric cytometry
data to explore the problem in multi-parameter data space, to
determine the error involved using contiguous regions in multiple
dimensions, and to illustrate expression of these three cell cycle
programs. To do this, we fixed and stained Molt4 cells for DNA,
cyclin A2 or cyclin B1, and PHH3 (3 samples each) and stained 3
samples from the same population for all 4 markers.
Data preprocessing
There is significant pre-processing of the data prior to the
extraction procedure. This consists of aggregate removal,
compensation, non-specific antibody back ground subtraction,
and rejoining cytokinetic cells (excluded in the aggregate removal
step) to the data set. These steps are illustrated in Figure S1.
Unambiguous trajectory
To perform the same procedure as illustrated for DNA content
with more complex data, it is necessary for the analytical setup to
provide data that unambiguously captures cells at each point along
the expression profile. At a minimum, for each dimension, we
need defined variation to create ends for each expression profile,
and over any region of each profile, ‘‘x’’, that oscillates, another
parameter, ‘‘y’’, must either be rising or falling sufficiently to allow
separation of the rise and fall of parameter, ‘‘x’’. The concept is
illustrated in Figure 3. Expression of PHH3 versus DNA content
provides a bivariate view that captures expression in G0/G1, S,
G2, and M. However, the mitotic cells that represent rising
expression of PHH3 map to the same data space as cells that
represent falling expression. The first are at the beginning of
mitosis and the last are at the end of mitosis (arrows, Figure 3A).
In this case, during the period when PHH3 is rising then falling,
DNA content does not change, and therefore, the rise and fall of
PHH3 cannot be resolved. Addition of cyclin A2 provides a
complete, unambiguous data trajectory that can be traced from
the beginning of the cell cycle to the end (Figure 3B). When
PHH3 is rising, so is cyclin A2, but when cyclin A2 is falling,
PHH3 is ,constant, then PHH3 falls when cyclin A2 is essentially
Figure 2. Segmentation of cytometric data. A simulated DNA
content distribution composed of the sum (A, dashed black line) of
multiple normal Gaussian components (A, thin blue lines) provides a
means to extract a perfect DNA content expression profile from idealize
typical cytometry histograms (B, blue circles). Segmenting the same
histogram by contiguous regions yields the same expression profile (B,
orange circles). The segmentation needs to account for measurement
variation at the ends of the histogram.
doi:10.1371/journal.pone.0030870.g002
Cell Cycle Expression
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Figure S1 shows that segmentation of the 2C stemline from the 4C
and higher sub-cycles requires the combination of the three
parameters, DNA content, PHH3, and cyclin A2. The unidirec-
tional progression of a hypothetical cell through the data space, as
depicted in Figure 3B can be verified by monitoring the passage
of a BrdU-label through segments of the data space [4].
Primary segmentation
Expression profile derivation for cyclin A2 and PHH3 can be
performed as in Figure 4. The approach is to create regions that
enclose statistically irreducible clusters (generally, at the ends and
corners of the data trajectory) and divide the ‘‘stretches’’ between
these clusters into regions with a significant number of events and
a goal of providing as many regions within the stretch as is
practical. This is valid provided that a cell’s residence in any
‘‘state’’ described by a segmented region is dependent on having
existed in a previous ‘‘state’’ described by an adjacent region at
an immediately earlier time, and that all previous regions are to
one side of the immediate region - i.e., the ‘‘states’’ and regions
are contiguous, ordered, and unidirectional. This requirement
can be satisfied either from direct experimentation - e.g., [4],
prior knowledge, or inferred logic. The directionality for cyclin
A2 versus PHH3 is shown by arrows in Figure 3B. The shape of
any bivariate region is conceptually straightforward. The goal is
to create adjacent, contiguous ‘‘sides’’ for tri- or tetragons that are
perpendicular to a line that follows the local slope of the data.
The other two sides are trivial, enclose the data, but could be
thought of as parallel to the local slope of the data. This approach
is an attempt to assign cells to a level of expression that
approximates two-dimensional Gaussian fitting – i.e., account for
appropriate variation in two dimensions. The second rule is to
bound data at the ends of ‘‘stretches’’ by regions that are not
further reducible. For example, R7 in Figure 4A, which encloses
G1 cells, cannot be made smaller without creating a center
statistic for expression that maps variation rather than expression,
since that region includes variation that is not further resolvable.
This is often not a difficult decision point, since the frequency
information, in this case denoted by contour lines, provides
information that can be used to determine the best placement of
the region boundary. Equally, when the data turn at a right
angle, the width of the data in each arm can direct the height and
width of the region at the corner. For example, the center and
width of the data region bounded by R42 and R44 can guide the
size of R43 (Figure 4B). In practice, segmenting orthogonal data
is very straight forward, whereas data with curvature is
problematic because of current software limitations. When data
are not orthogonal (e.g., the data captured by regions, R15
through R24, Figure 4A), the intent is to follow the two
dimensional peak range (i.e., the backbone), distributing the data
within a region in a manner perpendicular to the slope. However,
we do not know of current software packages that provide the
ability to create the desired region shape or eliminate region-to-
region overlap with any assurance. For the data presented in
Figures 4, 5, 6, 7, to ensure non-overlap and comprehensive
inclusion, we calculated the region vertices in a spreadsheet
program, then directly modified the ‘‘wlx’’ file (an ‘‘XML’’
descriptor file) in WinList.
Expression profiles of cyclin A2 and PHH3
Figure 5 shows the expression profiles of cyclin A2 and PHH3,
directly measured from the regions in Figure 4. The entire cycle,
emphasizing interphase is shown in Figure 5A. The detail that
occurred in late G2 and mitosis (represented by 4% of the cell
population) is shown in Figure 5B. These data are the composite
results from three independent assays of the same population – i.e.,
Figure 3. Defining ambiguity. Molt4 cells were stained for phospho-S10-histone H3 (PHH3-A488), cyclin A2 (Cyclin A2-A647), and DNA content. A:
typical view for counting mitotic cells (green dots). This view provides ambiguous data vis-a `-vis profile extraction since the cells between the G2
cluster and the bulk of mitotic events at the highest PHH3 levels represent cells that were in the processes of net gain and net loss of PHH3 (A, dual
arrows). The ambiguity can be resolved by plotting PHH3 versus cyclin A2 (B). Arrows show the direction of movement through the data space of cell
traversing the cell cycle.
doi:10.1371/journal.pone.0030870.g003
Cell Cycle Expression
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measured and analyzed independently. In this case, the cyclin A2
probe was labeled with Alexa Fluor 647 and the PHH3 probe with
Alexa Fluor 488 to minimize spectral overlap. The data set
contains staining error and sampling error. The analysis adds
analytical error with respect to region size differences. This error is
low for measuring center values of expression but larger for
establishing the frequency to which a specific level belongs. This is
relatively easy to understand. Since the profiles are built on
cumulative frequency data, any non-random variation in setting
an early region is propagated through the entire curve as a shift.
Thus, variation in setting R7 (the G1 region), which is first and
contains ,34% of the events, is propagated as a shift that shows
up dramatically at the end of the cell cycle where profile dynamics
are abrupt. Nevertheless, the error is acceptable and small relative
to the inability to obtain robust profiles by any other currently
practiced technology.
Expression of cyclin A2
The features of cyclin A2 expression are as expected – net
synthesis of cyclin A2 beginning at the G1/S boundary.
Expression increases in two phases. The first is an approximately
linear phase (fits a second order polynomial from Frequency values
of 0.38 to 0.7) and the second is exponential (fits an exponential
function from Frequency=0.7 to 0.95). See Figure S2 for fitting
information. There is evidence for two cell cycle transcriptional
modes - see references in [15,16], which may in part explain the
two-phase shape of the interphase expression of cyclin A2. In late
G2, cyclin A2 expression abruptly peaks and declines as these cells
entered mitosis, as determined by elevated PHH3 expression. The
abrupt decrease in cyclin A2 levels apparently stabilizes at a new
steady state that is maintained for most of the early period of
mitosis. We have little detailed information for this period, since
the cells are not further divided into individual states and therefore
expression is represented by one value. The cells that comprise this
Figure 4. Segmentation in two dimensions. Molt4 cells were stained as in Figure 3. A: segmentation of interphase; B: segmentation of mitosis
and the beginning of interphase (R48). For a description of the logic, see the text.
doi:10.1371/journal.pone.0030870.g004
Figure 5. Expression profiles of cyclin A2 and PHH3. Three samples of Molt4 cells from the same culture were fixed, stained (as in Figure 3),
and measured independently. Segmentation was as in Figure 4. Expression information and frequency calculations were as described in the text.
doi:10.1371/journal.pone.0030870.g005
Cell Cycle Expression
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the last quarter of mitosis, cyclin A2 is dramatically degraded to
levels that are below our ability to detect by this approach. These
interpretations are consistent with current narrative models of
cyclin A2 expression in mitosis [18]. This two step decline in cyclin
A2 expression, which could be unique to these cells and/or unique
to this experiment, is important, since the easiest explanation is
that Anaphase Promoting Complex/Cyclosome (APC/C) is
activated early but held in check during most of prophase and
then dominates after nuclear membrane breakdown. The slight
decrease in early prophase may not be an important point for
large-view biology, but for mathematical models of cell regulatory
biochemistry, subtle results like this, should be useful for model
validation. Figure 6 compares the bivariate histogram and
expression data for mitosis. It is significant that even with relatively
few cells occupying any one region, the variation in this analysis is
relatively low by biology standards. This figure also illustrates that
important features like the first period of cyclin A2 decline are
readily appreciated from the extracted profile while in the
bivariate (in log-log space) are too subtle to be readily noticed.
Thus, the act of profile extraction is more instructive than visual
inspection of bivariate data.
Expression of PHH3
Histone H3 is phosphorylated more often at serine 10 when
cells are in mitosis. In general, it is a relatively good marker for
mitotic cells in that it increases very early in prophase and is still
elevated when cells end cytokinesis. This is obvious from the
expression profile. Like for cyclin A2, the state wherein PHH3 is
maximum and cyclin A2 is at a mitotic plateau (in these cells) is
relatively long and uniform in expression of both epitopes,
therefore we lose time based expression information. In
Figure 6B, we have added lines (black) that might be more
probable, if we had information at a finer resolution. PHH3 is also
Figure 6. Information details: cyclin A2 and PHH3 expression. Molt 4 cells were stained and analyzed as in Figures 3, 4, and 5. A: brackets
show are of cyclin A2 decrease in early mitosis; small arrow points to ‘‘new born’’ cells; large arrow points to large cluster in early mitosis, largely
composes of prophase cells. B: gray zone highlights the data derived from bracketed segments in A; small arrow points to data derived from the large
mitotic cluster in A; added lines indicate expected expression profile if more data could be obtain within the large cluster in A.
doi:10.1371/journal.pone.0030870.g006
Figure 7. DNA expression profile extraction. A: profile extraction by indirect means. The DNA values were obtained for the cells falling within
regions from cyclin A2 vs PHH3 plots as in Figure 4. Error bars are SEM. B: direct extraction compared to indirect. The line traces the data in A; the
error bars are the 95% confidence intervals. Circles represent values calculated from each of three Molt4 data sets, derived by directly segmenting
DNA histograms as demonstrated in Figure 2.
doi:10.1371/journal.pone.0030870.g007
Cell Cycle Expression
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G1 (arrow, Figure 6A). These are cells that have recently divided.
This population correlates with a similar population marked by an
antibody reactive with phospho-S780-Rb (unpublished data), and
that state displays BrdU-labeled cells prior to the bulk of G1 cells
in kinetic experiments [4].
DNA content and indirect profile derivation
In principle, it is possible to derive additional parameter
expression profiles from the regions set up as in Figure 4, since
that set of regions unambiguously traverses the entire cell cycle.
The caveat is that any expression profile that is derived should not
oscillate within any single region, since this would create ambiguity
for that parameter. Additionally, there is a problem with using
regions set up on a bivariate to indirectly derive third parameter
expression. The data trajectory can be visualized as a worm
contorted through three dimensional data space. Regions set up
on two parameters are unlikely to appropriately have the correct
orientation with respect to the three dimensional trajectory, since
current software correlates the third parameter orthogonal to the
plane of the bivariate within the bivariate region. To ask whether
we can accept the error involved, we derived the expression profile
for DNA content from the regions set as in Figure 4 and
compared the results to expression profile data for each replicate,
derived from single parameter DNA histograms as in Figure 2.
The results are shown in Figure 7. It is clear that in this instance,
the error was acceptable. Figure 7A shows the DNA expression
profile derived indirectly with error bars equal to SEM. Figure 7B
shows the same plot without symbols and error bars equal to the
95% confidence intervals. The data are from single dimension
histograms for each replicate, analyzed independently - i.e., there
is no relationship to the regions between analyses other than that
nine regions were used in each instance. It is clear that the directly
derived profiles (Figure 7B) and the profile derived indirectly
agree exceptionally well. An added benefit to the indirect method
(in this case) is that the boundary at G1/S (arrows) is better defined
because immunofluorescent detection of cyclin A2 is a more
sensitive marker for S phase than is DNA content measured by dye
fluorescence.
Cyclin B1 expression
In this series of stained samples, the same population of Molt4
cells used for cyclin A2 and PHH3 (above) were stained for cyclin
B1, PHH3, and DNA content. The purpose was to obtain the
cleanest measure of cyclin B1 (i.e., without fluorescence compen-
sation) and to test the ability to measure cyclins A2 and B1
independently and put them back together through the frequency
domain. Figure 8 shows segmentation of flow cytometry data for
cyclin B1 versus PHH3 for a sample from the same population of
Molt4 cells for which the cyclin A2 analyses were made.
Essentially, the cytometric data patterns look similar from this
view, reflecting the similar shapes of the expression profiles for
these two cell cycle regulated proteins. We can measure cyclin B1
in G1, earlier than cyclin A2, and the subsequent rise cyclin B1,
peaking at the G2/M transition, can be fit by a compound
equation with two exponential components (Figure S2). Appar-
ently, both cyclins are expressed at one rate through S and a
second, increased rate in G2, with cyclin B1 affected more
dramatically. This comparison is shown in Figure 9C.I n
Figure 9, the data sets for cyclin A2 and cyclin B1 (3
independently analyzed samples of each) are co-plotted. In
Figure 9A/9B, the PHH3 profiles from the two data sets are
co-plotted, demonstrating remarkable accuracy for two indepen-
dently stained and measured samples, and independent analyses of
the two data sets. The agreement in the two PHH3 profiles
validates co-plotting of the cyclins with the features of each cyclin,
relative to the other, valid as well. As independent confirmation,
the analysis shows that cyclin A2 expression decreases to
background levels prior to a similar decrease in cyclin B1
(Figure 9D), which is known to be the case [18]. Figure 9D
(inset) shows that both sets of data indicate a decrease in both
cyclins at the same time in the beginning of M when PHH3 is
rising. This adds weight the idea that this is a real event, at least for
this cell line under the culture conditions at the time of the
experiment, and if more generally observed, should eventually be
accounted in mathematical models of the biochemistry of mitotic
entry. The data presented in Figure 9 show that by the expression
profile extraction approach, the relative expression behavior of an
essentially unlimited number of biomarkers can be assessed as a
Figure 8. Segmentation for cyclin B1 and PHH3. The approach is as in Figure 4 with differences due to the pattern created by the relationship
between cyclin B1 and PHH3. A:interphase segmentation. B: mitotic segmentation.
doi:10.1371/journal.pone.0030870.g008
Cell Cycle Expression
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and analysis, and quantitatively put together as a whole analysis.
This then becomes a powerful approach to validating mathemat-
ical models of the cell cycle. Figure 10 shows a close-up of mitosis
from the view of both analyses. In this figure, the means for the
two sets of PHH3 expression data are plotted as one set,
demonstrating an increase in information by (1) more points
defining PHH3 during the periods of cyclin degradation (arrow)
and (2) the temporal offsets of cyclins A2 and B1 degradation and
PHH3 dephosphorylation.
Comparison of unified and independent analyses
Improvements in instrumentation, antibody specificity and
affinity, and fluorescence labeling probes have colluded in recent
years to push the possibility of multiparameter cytometric analyses
to 17 or more biomarkers [19]. However, fluorescence spectral
overlap and the general non-availability of labeled antibodies often
reduce the practical number of simultaneous biomarkers to much
less than this. In analyses like we have presented here, where
expression does not equal well-separated clusters of ‘‘negative’’
and ‘‘positive’’ cells but rather forms a continuum from low to high
expression, the spectral overlap problems are even more
inhibitory. This is something that we have suspected or known,
but is difficult to demonstrate. We performed the measurements
and analyses presented in Figures 11, 12, 13 to (1) further
validate that the composite analyses in Figure 10 was correct, and
(2) to evaluate the impact of spectral compensation for the overlap
of Alexa Fluor 488 (on the PHH3 antibody) and phycoerythrin (on
the cyclin A2 antibody). Three samples from the same population
of cells used to generate the ‘‘single color’’ cyclins A2 and B1 data
were stained for cyclin B1 (Alexa Fluor 647), cyclin A2
(phycoerythrin), PHH3 (Alexa Fluor 488), and DNA content
(DAPI). Bivariate plots of the resulting data for one sample, and
the segmentation scheme are shown in Figure 11. We used a
different segmentation scheme that takes advantage of the
correlation between cyclins A2 and B1 and the early rise of cyclin
B1 to produce a smaller base cluster in G1 (orange dots,
Figure 9. Overlayed expression profiles of cyclins A2 and B1. Overlays of expression profiles for PHH3 (A, B) from the data set Molt4 cells
stained for cyclin A2, PHH3, and DNA content (labeled PHH3 from A2) presented in Figure 5, and from cells stained for cyclin B1, PHH3, and DNA
content (labeled PHH3 from B1). C, D: overlays of expression profiles for cyclin A2 and cyclin B1 obtained independently on the same samples. Inset in
D: zoomed view of initial decrease in both cyclins as cells enter mitosis. In A, B, and C, means (of median specific fluorescence) are shown. In D, error
bars are SEM.
doi:10.1371/journal.pone.0030870.g009
Figure 10. Joined expression profiles for PHH3, and overlayed
profiles for cyclins A2 and B1: mitotic view. For PHH3, means
values are shown as in Figure 9, but each data set has been joined. The
data density along the profile is enhanced; the arrow points to region of
obviously enhanced data density.
doi:10.1371/journal.pone.0030870.g010
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affected the data. Additionally, since cyclins A2 and B1 were
correlated, we could dissect mitosis in more detail, examining the
periods of time when first cyclin A2 and then cyclin B1 is
degraded. The segmentation starts in Figure 11A with the region
labeled ‘‘1’’, then jumps to Figure 11B to region ‘‘2’’. The
consecutive regions move unidirectionally from ‘‘2’’ to ‘‘21’’
following the bivariate synthesis pattern of the two cyclins in
interphase. The next region, ‘‘22’’, appears in Figure 11A with
consecutive, unlabeled regions ending at ‘‘34’’. This region set is
very similar to the mitotic regions in Figure 4B. The next region,
‘‘35’’, starts in Figure 11C and ends just before the terminal cluster
in this bivariate plot. Regions ‘‘39’’ and ‘‘40’’ finish the sequence
and are shown in the three dimension view of PHH3, cyclin B1,
and cyclin A2 expression in mitosis (Figure 11D). The expression
profile data for each of the three measured samples are plotted for
cyclin A2 (black circles) and PHH3 (blue circles) with the ‘‘single
color’’ data of Figure 5 (red and green data) in Figure 12.I ti s
obvious the PHH3 data are not different and for interphase and
early mitosis, the cyclin A2 data match as well. However, the
cyclin A2 data appear to be lower in values than expected (from
‘‘single color’’ data) when cyclin A2 was actively degraded in
mitosis. This is also the data that are most sensitive to spectral
compensation problems and where event numbers are small. Co-
plotting of the multi-color (MC) cyclin B1 data with ‘‘single color’’
(SC) data in Figure 13B show that cyclin B1 was not subject to
the same errors. The cyclin B1 probe, labeled with Alexa Fluor
647 was not subject to spectral overlap problems and compensa-
tion was not employed. Figure 13A shows the overlay of multi-
color PHH3 with single color PHH3 from the cyclin B1 series of
samples and shows identity. The payoff from multiparametric data
is enhanced clarity of information as shown from the cyclin B1
Figure 11. Segmentation of multiparametric data. Samples from the same Molt4 population as shown in previous figures were stained for
cyclins A2, B1, PHH3, and DNA content. Segmentation is more complex then single cyclin stained samples, requiring four bivariate views. The first
segment (labeled ‘‘1’’) begins in A (cyclin A2 vs. PHH3) then jumps to B, which is a plot of cyclin A2 vs. cyclin B1 for interphase cells (NOT gated for
mitotic cells identified by a region (not shown) set as in Figure S1), and begins with ‘‘2’’ and ends with ‘‘21’’. The next segment is back in A, labeled
‘‘22’’ and ends at ‘‘34’’. The next segment, ‘‘35’’ is in C, which is a plot of cyclin A2 vs. cyclin B1 for mitotic cells (AND gated for mitotic cells as in Figure
S1). The final cluster is segmented in a bivariate of PHH3 vs. cyclin B1 (not shown). D shows resolution of the last mitotic cluster by color (cyan,
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regions set on the cyclin A2 versus PHH3 plot on the region that
defines the period of cyclin A2 degradation. These measurements
are not possible in ‘‘single color’’ cyclin B1 data.
Additional Discussion
Here we presented the case for extraction of the cell cycle
expression of biomarker sets defined by antibody reactivity and
DNA binding dyes that requires two antibodies, reactive with one
Figure 12. Expression profiles from multi-parametric data. PHH3 (green) and cyclin A2 (red) profiles, extracted from single cyclin sample data,
are co-plotted with PHH3 (blue) and cyclin A2, extracted from multi-cyclin sample data, in three views that emphasize the entire cell cycle (top), G2
and M (lower left) and mitosis (lower right).
doi:10.1371/journal.pone.0030870.g012
Figure 13. Expression profiles from multiparametric data. Joined PHH3 profiles extracted from single cyclin sample data (both cyclins A2 and
B1) and multi-cyclin data are co-plotted (left). A cyclin B1 expression profile extracted from single cyclin data (SC) is co-plotted with an expression
profile extracted from multi-cyclin data (MC).
doi:10.1371/journal.pone.0030870.g013
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and the DNA dye, and at least one other marker of interest.
Analytically, this system of measures and analysis has no limits
provided that multi-variate data can be obtained that ‘‘worms’’
unidirectionally through multi-variate data space unambiguously
(in the simplest version, that is what a mitotic cyclin, a mitotic
marker, and DNA content provide). Practically, the system is
limited by the availability of high quality (high specificity and high
affinity) antibodies. Nevertheless, the current catalog of readily
available probes that meet these requirements is quite large, and
significant studies could be designed to capture expression data for
a large set of cell cycle related epitopes.
Aside from natural curiosity, our current drive for this work is to
provide a means to validate mathematical models of the cell cycle
based on systems of ordinary differential equations (unpublished
data). As presented here, there are two problems that we have not
addressed. The first is that this measurement system produces
correlated, relative expression data that provides timing informa-
tion but not data in a final form that reflects expression molecule
for molecule. The second is that use of cell frequency as a
surrogate for time needs an additional transformation to account
for the one mitotic cell giving rise to two G1 cells. Each of these
problems can be addressed, and we have addressed them in other
publications. To address the first, we used the same example
measurement system as this communication, but used the ‘‘single
color’’ files to generate a relative relationship between expression
of one epitope and expression of a second (in the example, cyclins
A2 and B1). That relationship was used to transform multi-variate
data to the same relative scale (unpublished data). To transform
those relative scales to a molecular scale, quantitative western
blotting with purified molecular standards, as we have previously
published [8,20], can be employed. This approach is not exact - it
is dependent on a high level of procedural rigor, and the
antibodies should have similar affinities and be of the same isotype.
Error is introduced by unequal affinities, differential recognition
by the secondary antibody, and any differences in epitope
masking. Nevertheless, this approach is a good and feasible first
step toward production of a model based on reality.
We used a concrete, but unsophisticated method for extracting
the expression information from cytometry data. First, we used
one or more bivariate plots to segment the data based on the local
bivariate slopes along a twisting data path. Aside from the simple
approach to chopping Gaussian distributed data into blocks, the
main problem with this approach is that any other parameters are
necessarily assumed to be orthogonal in the 3rd dimension relative
to the X and Y of the bivariate plot. They often are not. However,
we showed in this paper that we don’t seem to pay a large penalty
for this. Most likely, this is because we are measuring centers and
over the entire span of the N dimensional data, the imprecision in
this approach has a small effect. Whatever the reason, empirically,
we have shown that this approach works. The reason that we
chose this approach is that current cytometry software is severely
limited with respect to analyzing multidimensional continuums.
There are two steps toward a more sophisticated approach. The
first is the create software with N-dimensional region setting. A
significant problem is that analyses of this type of data are almost
completely visually guided and exactly how to approach
dimensionality past three is not clear. A next, second step would
be to write N-dimensional Gaussian component modeling. We
have used this approach in single dimensions with good results
[8,21]. The problems with this is that most immunofluorescence
distributions approximate normal or log-normal distributions, but
often not exactly, and often in parts of the data path, the number
of events populating a region may be too low for good fits,
especially in N dimensions. Further, it is unclear at the outset that
the penalty that any gains in accuracy will offset the relative
robustness and reproducibility of the current approach. Currently,
writing software for multi-dimensional analysis is an expensive and
time-intensive undertaking. The value of the current approach is
that with minor modifications (chiefly, easy insurance that regions
don’t under- or over-lap each other), current software could be
revised to make this approach easily accessible. An intriguing new
development is embodied by a concept termed ‘‘probability state
modeling’’ [22]. In this system, data are clustered along profiles
that, for the type of work presented here, look exactly like
expression profiles. Multi-dimensional data are analyzed by
assigning data to sequential profiles and the correlated nature of
the data sequentially restricts the data to regions along the profile
X axis until uncertainties are minimized. The result is the best
partitioning of the data along an expression profile that is
statistically supported in a rigorous and sophisticated manner. It
seems to us that this approach is the right direction for the type of
analysis presented here, however, it is difficult to see at this time




Molt4 cells ([23]; obtained from Keith Shults) were cultured in
RMPI 1640 medium without phenol red with 10% fetal bovine
serum and gentamycin at 37uC with 5% CO2 in T75 flasks. Cells
were split approximately twice per week to maintain concentra-
tions between 3610
5–1610
6. Samples were from exponentially
growing cultures.
Cell Fixation and staining
Samples were washed and fixed with formaldehyde and
methanol, stored at 220uC until staining, then stained for cyclin
A2, cyclin B1, PHH3, and DNA content as previously published in
detail [24]. Three samples were stained simultaneously for cyclin
A2, PHH3, and DNA and three samples were stained for cyclin
B1, PHH3, and DNA by indirect method for each cyclin. A third
set of three samples was stained with directly conjugated




6 fixed cells per sample were stained with the following.
For indirect staining, cyclin B1 (clone GS11, BD Biosciences, San
Jose, CA) and cyclin A2 (Beckman Coulter, Brea, CA) antibodies
were both used at 0.125 ug in 50 ul volume of PBS-BSA
(phosphate buffered saline with 2% bovine serum albumin,
Sigma-Aldrich, St. Louis, MO). The secondary antibody, used at
0.25 ug per sample in 50 ul PBS-BSA, was goat anti-mouse
conjugated to Alexa Fluor 647 (GAM-A647) from Invitrogen/
Molecular Probes (Carlsbad, CA). The cyclin B1 antibody used for
direct staining was the same clone described above, conjugated to
Alexa Fluor 647 (A647) with kit from Molecular Probes, used
according to manufacturer’s directions. 0.06 ug in 50 ul PBS-BSA
per sample was used for staining. The cyclin A2 antibody used for
direct staining was the same clone as above but conjugated to
phycoerythrin (Cyclin A2-PE, Beckman Coulter). This was used at
0.125 ug sample. The PHH3 antibody, directly conjugated to
Alexa Fluor 488 (#9708, Cell Signaling Technology, Danvers,
MA) was used at 0.0125 ug per sample in all reactions. 49,6-
diamidino-2-phenylindole (DAPI) was purchased from Sigma-
Aldrich and used at 0.25 ug/ml in PBS (2610
6 cells, 500 ul PBS).
Cell Cycle Expression
PLoS ONE | www.plosone.org 11 February 2012 | Volume 7 | Issue 2 | e30870Cytometry
Samples were measured on an LSR II with uv, violet, blue, and
red excitation, using stock filters for blue (DAPI), green (A488-
PHH3), orange (PE-cyclin A2), and red (A647-cyclin A2 or B1)
fluorescence.
Software
WinList 7.0 (Verity Software House, Topsham, ME) was used
for all data file processing and primary analysis. Prism 5.04
(Graphpad, graphpad.com) was used for non-linear regression and
plotting expression profiles. Excel 2007 (Microsoft, Redman, WA)
was used to generate the multi-gaussian model of a DNA
histogram. Prism was used to plot the results. For segmentation
of bivariate plots, we used the normal visual/mouse click interface
of WinList to set preliminary partial regions that followed the local
slope across the bivariate data peak values from each region. We
then calculated the vertice positions for bounding lines that would
be orthogonal to the local slope. The vertice information was
obtained from a hypertext file written by the program. This was
manually adjusted to the new calculated vertices. In this manner,
we could ensure that the regions were not over or under-lapping.
This logic was used for regions where data runs were not
orthogonal to an axis. For other region logic, consult the text or
Figure legends.
Supporting Information
Figure S1 Data preprocessing. There are several steps to
prepare cytometry list mode data for profile extraction. A: removal
of aggregates and debris by a 99% contour gate on the singlet
population from a plot of pulse width (UV 440-W) vs. integrated
pulse (DNA) for the DAPI signal. Arrow points to mitotic events
(red dots) that are not included in this gate. These represent some
anaphase, telophase, and cytokinetic cells. B: mitotic gate (R3)
based on PHH3 fluorescence of cells gated from the Singlet Gate
(R2). Background subtraction for cyclin A2 or B1 is accomplished
by plotting cyclin fluorescence versus side scatter (SSC-A). The G1
cells are negative for cyclin A2 and partially negative for cyclin B1.
We use the compensation mechanism to subtract from all data an
amount of cyclin staining related fluorescence that rises in G1 as a
function of cell size. C: cyclin A2 data prior to subtraction. D:
cyclin A2 data after subtraction. If everything goes correctly, the
median fluorescence of G1 cells should be close to zero. To
remove some outliers, a restricting gate is applied to a cyclin
fluorescence vs. DNA plot of interphase cells (AND gated on R2,
NOT gated on R3). This removes doublets, aberrant S phase cells
without cyclins, and outliers. E: gate (R5) is set at .99% contour
level. F: a final outlier gate is set on interphase cells plus mitotic
cells that have been gated ((R2 AND R5) OR R3). The final gating
strategy uses ((R2 AND R4 AND R5) OR R3)) to obtain an entire
cell cycle distribution of the 2C stem line. Sometimes additional
gates are applied on SSC vs. cyclin fluorescence or DNA vs.
acquisition time (position in the list). The objective of either of
these is to further clean up outliers.
(TIF)
Figure S2 Two-phase, differential rates of accumula-
tion of both cyclin A2 and B1 expression in interphase
can be fit to a complex equations. Cyclin A2 was fit to a
compound equation: y=c+ bx + ax
2 from 0.38 to 0.7, and c*e
kx
from 0.7 to 0.95. Cyclin B1 was fit to y=c1*e
k1x from 0.32 to 0.79
and y=c2*e
k2x from 0.79 to 0.95. Therefore, both cyclins appear
to have an early, slow rate and a late, fast rate with cyclin B1
having a more exponential character. The fits were done to
specific fluorescence values from single cyclin analyses using
experimental procedures that make the amplitude relationships
relevant. Therefore, cyclin B1 accumulates at slower rate during S
phase than cyclin A2 but at a faster rate in late S/G2. It is also




The authors wish to thank Vincent Shankey (Beckman Coulter
Corporation) for the generous gift of cyclin A2 antibody.
Author Contributions
Conceived and designed the experiments: JWJ. Performed the experi-
ments: TS. Analyzed the data: JWJ. Wrote the paper: JWJ. Extensive
discussion of the procedural details of analysis: JWJ JA MCW SNS.
References
1. Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganos F (1996) Cytometry of
cyclin proteins. Cytometry 25: 1–13.
2. Darzynkiewicz Z, Crissman H, Jacobberger JW (2004) Cytometry of the cell
cycle: cycling through history. Cytometry A 58: 21–32.
3. Sramkoski RM, Wormsley SW, Bolton WE, Crumpler DC, Jacobberger JW
(1999) Simultaneous detection of cyclin B1, p105, and DNA content provides
complete cell cycle phase fraction analysis of cells that endoreduplicate.
Cytometry 35: 274–283.
4. Jacobberger JW, Frisa PS, Sramkoski RM, Stefan T, Shults KE, et al. (2008) A
new biomarker for mitotic cells. Cytometry A 73: 5–15.
5. Soni DV, Sramkoski RM, Lam M, Stefan T, Jacobberger JW (2008) Cyclin B1 is
rate limiting but not essential for mitotic entry and progression in mammalian
somatic cells. Cell Cycle 7: 1285–1300.
6. Frisa PS, Jacobberger JW (2002) Cell density related gene expression: SV40
large T antigen levels in immortalized astrocyte lines. BMC Cell Biol 3: 10.
7. Jacobberger JW, Sramkoski RM, Wormsley SB, Bolton WE (1999) Estimation of
kinetic cell-cycle-related gene expression in G1 and G2 phases from
immunofluorescence flow cytometry data. Cytometry 35: 284–289.
8. Frisa PS, Jacobberger JW (2009) Cell cycle-related cyclin B1 quantification.
PLoS One 4: e7064.
9. Sible JC, Tyson JJ (2007) Mathematical modeling as a tool for investigating cell
cycle control networks. Methods 41: 238–247.
10. Walker PMB (1954) The Mitotic Index and Interphase Processes. J Exp Biol 31:
8–15.
11. Watson JV (1991) Introduction to flow cytometry. Cambridge: Cambridge
University Press. 443 p.
12. Gray JW, Dolbeare F, Pallavicini MG (1990) Quantitative cell-cycle analysis. In:
Melamed MR, Lindmo T, Mendelsohn ML, eds. Flow cytometry and cell
sorting. Second ed. New York: Wiley-Liss. 824 p.
13. Fried J (1976) Method for the quantitative evaluation of data from flow
microfluorometry. Comput Biomed Res 9: 263–276.
14. Tomasoni D, Lupi M, Brikci FB, Ubezio P (2003) Timing the changes of cyclin
E cell content in G1 in exponentially growing cells. Exp Cell Res 288: 158–167.
15. Zhu W, Giangrande PH, Nevins JR (2004) E2Fs link the control of G1/S and
G2/M transcription. EMBO J 23: 4615–4626.
16. Laoukili J, Alvarez M, Meijer LA, Stahl M, Mohammed S, et al. (2008)
Activation of FoxM1 during G2 requires cyclin A/Cdk-dependent relief of
autorepression by the FoxM1 N-terminal domain. Mol Cell Biol 28: 3076–3087.
17. Stefan T, Jacobberger JW (2011) Laser scanning cytometry of mitosis: state and
stage analysis. Methods Cell Biol 102: 341–372.
18. Pines J (2006) Mitosis: a matter of getting rid of the right protein at the right
time. Trends Cell Biol 16: 55–63.
19. Perfetto SP, Chattopadhyay PK, Roederer M (2004) Seventeen-colour flow
cytometry: unravelling the immune system. Nat Rev Immunol 4: 648–655.
20. Frisa PS, Lanford RE, Jacobberger JW (2000) Molecular quantification of cell
cycle-related gene expression at the protein level. Cytometry 39: 79–89.
21. Sladek TL, Jacobberger JW (1993) Flow cytometric titration of retroviral
expression vectors: comparison of methods for analysis of immunofluorescence
Cell Cycle Expression
PLoS ONE | www.plosone.org 12 February 2012 | Volume 7 | Issue 2 | e30870histograms derived from cells expressing low antigen levels. Cytometry 14:
23–31.
22. Bagwell CB (2011) Breaking the dimensionality barrier. Methods Mol Biol 699:
31–51.
23. Minowada J, Onuma T, Moore GE (1972) Rosette-forming human lymphoid
cell lines. I. Establishment and evidence for origin of thymus-derived
lymphocytes. J Natl Cancer Inst 49: 891–895.
24. Jacobberger JW, Sramkoski RM, Stefan T (2011) Multiparameter cell cycle
analysis. Methods Mol Biol 699: 229–249.
Cell Cycle Expression
PLoS ONE | www.plosone.org 13 February 2012 | Volume 7 | Issue 2 | e30870